Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-52.29
Price to sales ratio
1.61

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3932
NTHI
NeOnc Technologies Holdings, Inc. - Common Stock
4.32 USD-3.79%-4.42%-10.00%-50.71%112.38 M USD
3938
ONCY
Oncolytics Biotech Inc. - Common Stock
0.93 USD+4.49%+5.68%+13.41%-22.50%111.00 M USD
3946
BDTX
Black Diamond Therapeutics, Inc. - Common Stock
1.90 USD-0.52%-3.55%+5.56%-35.59%108.87 M USD
3960
ENLV
Enlivex Ltd. - Ordinary Shares
6.67 USD-2.77%+1261.22%+839.44%+429.37%105.56 M USD

Frequently asked questions about Fortress Biotech, Inc. - Common Stock

What is the Fortress Biotech, Inc. - Common Stock stock price today?

The current price of Fortress Biotech, Inc. - Common Stock (FBIO) is 3.3. Over the past 24 hours, the stock has changed by 0.00%. Follow the FBIO chart for real-time price dynamics.

What is the stock ticker of Fortress Biotech, Inc. - Common Stock?

Fortress Biotech, Inc. - Common Stock trades under the ticker FBIO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Fortress Biotech, Inc. - Common Stock stock going up?

FBIO has changed by +8.91% over the last week, +13.79% over the last month, and +70.98% over the last year. Review the chart to see whether the current move is part of a broader trend.

Does Fortress Biotech, Inc. - Common Stock release financial reports?

Yes. You can track Fortress Biotech, Inc. - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What was Fortress Biotech, Inc. - Common Stock net income for the last quarter?

Fortress Biotech, Inc. - Common Stock reported net income of 110.37 M for the last quarter. The previous quarter showed -3.94 M, which means net income changed by +2903.48%.

How many employees does Fortress Biotech, Inc. - Common Stock have?

As of the latest available data, Fortress Biotech, Inc. - Common Stock has 78 employees. Workforce size can provide additional context about the company's scale and operations.

What is Fortress Biotech, Inc. - Common Stock EBITDA?

Fortress Biotech, Inc. - Common Stock EBITDA is -3.46 M, and its EBITDA margin is -21.6%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Fortress Biotech, Inc. - Common Stock stock?

You can buy Fortress Biotech, Inc. - Common Stock (FBIO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Fortress Biotech, Inc. - Common Stock stock?

Investing in Fortress Biotech, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the FBIO chart and related analysis on metatrader.com as part of your research.

Fortress Biotech, Inc. - Common Stock

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.

News